Prica Corina, Hascoet Martine, Bourin Michel
EA 3256 Neurobiologie de l'anxiété et de la dépression, Faculté de Médecine, 1 rue Gaston Veil, BP 53508, 44035 Nantes Cedex 01, France.
Behav Brain Res. 2008 Aug 5;191(1):49-54. doi: 10.1016/j.bbr.2008.03.007. Epub 2008 Mar 16.
Lamotrigine has been found to be efficacious in the acute management of bipolar depression and long-term management of bipolar disorder, especially in delaying depressive recurrence, either as monotherapy or as adjunctive therapy. Lamotrigine is also an antiepileptic drug, and is efficient in the treatment of focal epilepsies. It is thought to act by inhibition of glutamate release through blockade of voltage-sensitivity sodium channels and stabilization of the neuronal membrane.
The scope of this study was to determinate if sodium channels are important for lamotrigine and other antidepressant to exert their antidepressant-like function.
This study assessed the effects of veratrine, a Na(+) channel opener on antidepressant effect of lamotrigine and others antidepressants: two tricyclic antidepressants (TCAs): imipramine, a mixed serotonergic noradrenergic reuptake inhibitor, desipramine, a specific noradrenergic reuptake inhibitor and a SSRI: paroxetine, the most potent selective serotonergic reuptake inhibitor, using an animal model of depression, the forced swimming test. Veratrine (0.125 mg/kg) and lamotrigine (16, 32 mg/kg) or antidepressants (16, 32 mg/kg) were given i.p. 45 and 30 min, respectively, before the test.
We observed that when combined with veratrine the antidepressant-like effect of lamotrigine was reversed, but the antidepressant-like effect of the imipramine, desipramine and paroxetine was not changed, indicating that the mechanism of action of lamotrigine is different from that of antidepressants.
已发现拉莫三嗪在双相抑郁的急性治疗及双相情感障碍的长期治疗中有效,尤其是在延迟抑郁复发方面,无论是作为单一疗法还是辅助疗法。拉莫三嗪也是一种抗癫痫药物,对局灶性癫痫的治疗有效。据认为,其作用机制是通过阻断电压敏感性钠通道抑制谷氨酸释放并稳定神经元膜。
本研究的范围是确定钠通道对于拉莫三嗪和其他抗抑郁药发挥其抗抑郁样功能是否重要。
本研究使用抑郁动物模型——强迫游泳试验,评估了藜芦碱(一种钠通道开放剂)对拉莫三嗪及其他抗抑郁药抗抑郁作用的影响:两种三环类抗抑郁药(TCAs):米帕明,一种混合性5-羟色胺能和去甲肾上腺素能再摄取抑制剂;地昔帕明,一种特异性去甲肾上腺素能再摄取抑制剂;以及一种选择性5-羟色胺再摄取抑制剂(SSRI):帕罗西汀,最强效的选择性5-羟色胺再摄取抑制剂。在试验前分别于45分钟和30分钟腹腔注射藜芦碱(0.125毫克/千克)和拉莫三嗪(16、32毫克/千克)或抗抑郁药(16、32毫克/千克)。
我们观察到,与藜芦碱合用时,拉莫三嗪的抗抑郁样作用被逆转,但米帕明、地昔帕明和帕罗西汀的抗抑郁样作用未改变,这表明拉莫三嗪的作用机制与抗抑郁药不同。